FDA Inspection 1030363 — Halo Pharmaceutical Canada Inc
The FDA completed an inspection of Halo Pharmaceutical Canada Inc on Sep 15, 2017 in Mirabel. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 15, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mirabel (Canada)